Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Current assets
Cash and cash equivalents (including restricted cash of $15 and $18, respectively)	$ 128	$ 115
Accounts receivable (net of allowance for doubtful accounts of $16 and $19, respectively)	412	462
Inventories:
Finished and in-process goods	240	221
Raw materials and supplies	94	92
Total current assets held for sale	0	6
Other current assets	57	44
Total current assets	931	940
Investments in unconsolidated entities	19	20
Deferred Income Taxes	0	8
Total long-term assets held for sale	0	2
Other assets, net	34	49
Property and equipment
Land	89	84
Buildings	285	291
Machinery and equipment	2,293	2,327
Property, plant and equipment, gross	2,667	2,702
Less accumulated depreciation	(1,826)	(1,778)
Property, plant and equipment, net	841	924
Goodwill	109	112
Other intangible assets, net	27	42
Total assets	1,961	2,097
Current liabilities
Accounts and drafts payable	384	402
Debt payable within one year	3,716	125
Interest payable	82	82
Income taxes payable	5	12
Accrued payroll and incentive compensation	52	47
Total current liabilities associated with assets held for sale	0	2
Other current liabilities	106	135
Total current liabilities	4,345	805
Long-term liabilities
Long-term debt	99	3,584
Long-term pension and post employment benefit obligations	221	262
Long-term deferred income taxes	15	11
Other long-term liabilities	195	177
Total liabilities	4,875	4,839
Deficit
Common stock—$0.01 par value; 300,000,000 shares authorized, 170,605,906 issued and 82,556,847 outstanding at December 31, 2018 and 2017	1	1
Paid-in capital	526	526
Treasury stock, at cost—88,049,059 shares	(296)	(296)
Accumulated other comprehensive income	(18)	(8)
Accumulated deficit	(3,125)	(2,964)
Total Momentive Specialty Chemicals Inc. shareholder’s deficit	(2,912)	(2,741)
Noncontrolling interest	(2)	(1)
Total deficit	(2,914)	(2,742)
Total liabilities and deficit	$ 1,961	$ 2,097